{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:05:36Z","timestamp":1766073936361,"version":"3.48.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To analyze the relationship between socioeconomic status and neovascular age-related macular degeneration outcomes and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective analysis of 1,449 patients diagnosed with neovascular age-related macular degeneration, treated with anti\u2013vascular endothelial growth factor between January 2016 and January 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Lower income was associated with poorer baseline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and final (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) best-corrected visual acuity. Worse final visual acuity correlated with lower baseline best-corrected visual acuity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), lower income (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05), and older age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001); insurance type did not (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.558). Non-Hispanic\/non-Latino patients exhibited a higher rate of delayed injections per scheduled visit than Hispanics (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.002). Ethnicity correlated with insurance status (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008); Hispanic or Latino patients more often had Medicaid or commercial insurance; non-Hispanics\/non-Latino patients more often had Medicare. Higher-income patients were more likely to receive aflibercept (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and faricimab (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.021). Hispanic or Latino were more likely to receive bevacizumab (OR 2.49;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), but insurance type modified this association (OR 3.42;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.010).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Lower income correlated with worse neovascular age-related macular degeneration visual outcomes, and the type of anti\u2013vascular endothelial growth factor treatment used varied across income and ethnicity groups, but not insurance type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004649","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T21:02:42Z","timestamp":1756846962000},"page":"115-124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["EFFECTS OF SOCIOECONOMIC FACTORS ON VISUAL OUTCOME AND MANAGEMENT OF PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"46","author":[{"given":"Normila","family":"Barthelemy","sequence":"first","affiliation":[{"name":"University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida;"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Tailor","sequence":"additional","affiliation":[{"name":"Olive View, Department of Ophthalmology, UCLA Medical Center, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanth","family":"Sridhar","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida;"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida; and"},{"name":"Olive View, Department of Ophthalmology, UCLA Medical Center, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilani","family":"Samarakoon","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse D.","family":"Sengillo","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida;"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archopht.123.3.321","article-title":"The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"100302","DOI":"10.1016\/j.xgen.2023.100302","article-title":"A systems biology approach uncovers novel disease mechanisms in age-related macular degeneration","volume":"3","author":"Orozco","year":"2023","journal-title":"Cell genomics"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","article-title":"Prevalence of age-related macular degeneration in the US in 2019","volume":"140","author":"Rein","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/cells10092483","article-title":"Potential therapeutic candidates for age-related macular degeneration (AMD)","volume":"10","author":"Nashine","year":"2021","journal-title":"Cells"},{"key":"R5-20251218","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New Engl J Med"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3928\/23258160-20210201-02","article-title":"Impact of delayed time to treatment on visual outcomes in neovascular AMD: data from the HARBOR study","volume":"52","author":"Goldberg","year":"2021","journal-title":"Ophthalmic Surg lasers Imaging Retina"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2105\/AJPH.92.7.1100","article-title":"Zip code caveat: bias due to spatiotemporal mismatches between zip codes and us census\u2013defined geographic areas\u2014the public health disparities geocoding project","volume":"92","author":"Krieger","year":"2002","journal-title":"Am J Public Health"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"e182716","DOI":"10.1001\/jamanetworkopen.2018.2716","article-title":"Value of neighborhood socioeconomic status in predicting risk of outcomes in studies that use electronic health record data","volume":"1","author":"Bhavsar","year":"2018","journal-title":"JAMA Netw Open"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09286586.2020.1786590","article-title":"Tutorial on biostatistics: longitudinal analysis of correlated continuous eye data","volume":"28","author":"Ying","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"R13-20251218","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09286586.2012.674614","article-title":"Regression methods when the eye is the unit of analysis","volume":"19","author":"Glynn","year":"2012","journal-title":"Ophthalmic Epidemiol"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","article-title":"Visual acuity measurements","volume":"30","author":"Holladay","year":"2004","journal-title":"J Cataract Refractive Surg"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20251218","first-page":"513","article-title":"Geographic disparity of severe vision loss-United States, 2009-2013","volume":"64","author":"Kirtland","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R18-20251218","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41433-019-0393-3","article-title":"Socio-economic status and outcomes for patients with age-related macular degeneration","volume":"33","author":"More","year":"2019","journal-title":"Eye"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/1120672120920783","article-title":"Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration","volume":"31","author":"Levinger","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.eye.6701978","article-title":"Smoking and age-related macular degeneration: a review of association","volume":"19","author":"Thornton","year":"2005","journal-title":"Eye"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related macular degeneration risk factors study group","volume":"118","author":"Hyman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R22-20251218","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0161-6420(00)00409-7","article-title":"Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: age-related eye disease study report number 3","volume":"107","year":"2000","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:00:17Z","timestamp":1766073617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004649","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}